BrunoBastosMD

Genitourinary Oncology

Staff

Overview of Dr. Bastos

Dr. Bruno Bastos is an oncologist in Miami, FL and is affiliated with multiple hospitals in the area, including Baptist Hospital of Miami and Cleveland Clinic Florida. He received his medical degree from Federal University of Bahia Faculty of Medicine and has been in practice 16 years. He is one of 22 doctors at Cleveland Clinic Florida and one of 58 doctors at Baptist Hospital of Miami who specialize in Oncology. He has more than 10 publications and over 150 citings.

Office
Baptist Health Miami Cancer Institute
8900 N Kendall Dr
Miami, FL 33176
Book by Phone+1(844) 243-9899
Is this information wrong?

Education & Training

Harvard Medical SchoolFellowship, Development Therapeutics, 2008 - 2009
Jackson Health System2005 - 2008
University of Miami/Jackson Health SystemResidency, Internal Medicine, 2002 - 2005
Federal University of Bahia Faculty of MedicineClass of 2001

Certifications & Licensure

FL State Medical License 2009 - 2025
MA State Medical License 2008 - 2011
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011, 2013

Clinical Trials

Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Start of enrollment: 2008 Aug 08
Active, not recruiting
Phase 3
Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer Start of enrollment: 2009 Jul 15
Completed
Phase 3
Expanded Treatment Protocol With LDK378 in ALK(+) NSCLC
No longer available
A Study of Abemaciclib (LY2835219) in Participants With Previously Treated KRAS Mutated Lung Cancer Start of enrollment: 2014 Oct 03
Active, not recruiting
Phase 3
A Study of BMS-986249 Alone and in Combination With Nivolumab in Advanced Solid Tumors Start of enrollment: 2017 Dec 06
Active, not recruiting
Phase 1, Phase 2
Join now to see all

Publications & Presentations

PubMed

First-in-human Phase I Trial of TPST-1120, an Inhibitor of PPARα, as Monotherapy or in Combination with Nivolumab, in Patients with Advanced Solid Tumors.
Mark Yarchoan, John D Powderly, Bruno R Bastos, Thomas B Karasic, Oxana V Crysler, Pamela N Munster, Meredith A McKean, Leisha A Emens, Yvonne M Saenger, Yasser Ged, R...> ;Cancer Research Communications. 2024 Apr 18
Characterization and impact of non-canonical WNT signaling on outcomes of urothelial carcinoma.
Margaret Meagher, Harris Krause, Andrew Elliott, Alex Farrell, Elisabeth I Heath, Christina Jamieson, Tyler F Stewart, Matt Oberley, Rana R McKay, Emmanuel S Antonarak...> ;Cancer Medicine. 2024 Apr 1
Phase I Study of Elraglusib (9-ING-41), a Glycogen Synthase Kinase-3β Inhibitor, as Monotherapy or Combined with Chemotherapy in Patients with Advanced Malignancies.
Davis, E., Benedito A Carneiro, Ludimila Cavalcante, Devalingam Mahalingam, Anwaar Saeed, Howard Safran, Wen Wee Ma, Andrew L Coveler, Steven Powell, Bruno Bastos, Eli...> ;Clinical Cancer Research. 2024 Feb 1
1 citations
Long-term Outcomes from a Phase 2 Study of Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer (SWOG S1314; NCT02177695).
Thomas W Flaig, Catherine M Tangen, Siamak Daneshmand, Ajjai Shivaram Alva, M Scott Lucia, David James McConkey, Dan Theodorescu, Amir Goldkorn, Matthew I Milowsky, Ri...> ;European Urology. 2023 Sep 1
2 citations
Malignant glioma subset from actuate 1801: Phase I/II study of 9-ING-41, GSK-3β inhibitor, monotherapy or combined with chemotherapy for refractory malignancies.
Yazmin Odia, Ludimila Cavalcante, Howard Safran, Steven Francis Powell, Pamela N Munster, Wen Wee Ma, Benedito A Carneiro, Bruno R Bastos, Stacy Mikrut, William Mikrut...> ;Neuro-Oncology Advances. 2022 Feb 7
36 citations
A Randomized Phase II Study of Coexpression Extrapolation (COXEN) with Neoadjuvant Chemotherapy for Bladder Cancer (SWOG S1314; NCT02177695).
Thomas W. Flaig, Catherine M. Tangen, Siamak Daneshmand, Ajjai Alva, Seth P. Lerner, M. Scott Lucia, David J. McConkey, Dan Theodorescu, Amir Goldkorn, Matthew I. Milo...> ;Clinical Cancer Research. 2021 May 1
7 citations
Transcriptional analysis of metastatic uveal melanoma survival nominates NRP1 as a therapeutic target.
Riyue Bao, Oliver Surriga, Daniel J Olson, Jacob B. Allred, Carrie Strand, Yuanyuan Zha, Timothy Carll, Brian W. Labadie, Bruno R. Bastos, Marcus O. Butler, David Hogg...> ;Melanoma Research. 2021 Feb 1
15 citations
Practical and cost-effective model to build and sustain a cardio-oncology program
Diego Sadler, Chakra P Chaulagain, Beatrice Alvarado, Robert Cubeddu, Elizabeth Stone, Thomas A. Samuel, Bruno R. Bastos, David Grossman, Chieh-Lin Fu, Evan W. Alley, ...> ;Cardio-Oncology. 2020 Jul 16
33 citations
Randomized phase II trial and tumor mutational spectrum analysis from cabozantinib versus chemotherapy in metastatic uveal melanoma (Alliance A091201)
Jason J. Luke, Daniel J Olson, Jacob B. Allred, Carrie Strand, Riyue Bao, Yuanyuan Zha, Timothy Carll, Brian W. Labadie, Bruno R. Bastos, Marcus O. Butler, David Hogg,...> ;Clinical Cancer Research. 2020 Feb 15
12 citations
Randomized phase 2 study of tivantinib plus erlotinib versus single-agent chemotherapy in previously treated KRAS mutant advanced non-small cell lung cancer.
David E. Gerber, Mark A. Socinski, Joel W. Neal, Heather A. Wakelee, Keisuke Shirai, Lecia V. Sequist, Rachel P. Rosovsky, Rogerio Lilenbaum, Bruno R. Bastos, Chao Hua...> ;Lung Cancer. 2018 Mar 1
Where is the Air
Schroeder, James Benjamin Gleason, Bastos B, Jinesh Mehta> ;Journal of Clinical and Diagnostic Research. 2017 Feb 1
23 citations
Phase I Studies of CBP501, a G2 Checkpoint Abrogator, as Monotherapy and in Combination with Cisplatin in Patients with Advanced Solid Tumors
Geoffrey I. Shapiro, Raoul Tibes, Michael S. Gordon, Bryan Y. Wong, Joseph Paul Eder, Mitesh J. Borad, David S. Mendelson, Nicholas J. Vogelzang, Bruno R. Bastos, Glen...> ;Clinical Cancer Research. 2011 May 15
55 citations
Phase I Safety, Pharmacokinetic, and Pharmacodynamic Study of ENMD-2076, a Novel Angiogenic and Aurora Kinase Inhibitor, in Patients with Advanced Solid Tumors
Jennifer R. Diamond, Bruno R. Bastos, Ryan J. Hansen, Daniel L. Gustafson, S. Gail Eckhardt, E. L. Kwak, Shuchi Sumant Pandya, Graham C. Fletcher, Todd M. Pitts, Gilli...> ;Clinical Cancer Research. 2011 Feb 15
14 citations
Efficacy and toxicity of chemoradiotherapy with carboplatin and irinotecan followed by consolidation docetaxel for unresectable stage III non-small cell lung cancer.
Bruno R. Bastos, Georges Hatoum, Gail Walker, Khaled A. Tolba, Christiane Takita, Jorge Gomez, Edgardo S. Santos, Gilberto Lopes, Luis E. Raez> ;Journal of Thoracic Oncology. 2010 Apr 1
Join now to see all